Djordje Filipovic

Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA.

Schweizerische Rückversicherungs-Gesellschaft AG provides reinsurance, insurance, and risk management solutions. The firm focuses on the property and casualty, life and health, and asset management sectors. The company was founded on May 1, 1883 and is headquartered in Zurich, Switzerland.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Founded in 1983, Fairfield Greenwich Group's (FGG) is a hedge fund manager located in New York City. They have additional offices in New York, London and Bermuda, and representative offices elsewhere in the US, Europe, Latin America and Asia and a joint venture in Singapore.

Nestle USA, Inc. produces dairy and bakery products. Its products include chocolate and confectionaries, beverages, ice cream, juices, milk products, pet food, prepared foods, and sports nutrition. The company is headquartered in Arlington, VA.

Helsana Versicherungen AG provides health and accident insurance services. It offers solutions in the areas of basic, supplementary, and accident insurance which protect people against financial consequences of illnesses, unfortunate incidents, disability, maternity, and long-term care in old age. The company was founded on June 20, 1996 and is headquartered in Duebendorf, Switzerland.

BioMedInvest AG I invests in companies located in Switzerland, Germany, Austria, France and Italy. The fund targets companies operating in the fields of drug development, focusing less on diagnostics and medical technology. It acts as lead/co-lead investor and provides financing for start-up to later stage and spin-off capital requirements with an investment size of CHF1 - CHF10 million.

VI Partners AG (VI Partners) is an independent venture capital firm founded in 2001. The firm is headquartered in Schwyz, Switzerland.

Nestlé Nespresso SA designs and manufactures espresso machines. The company was founded in 1986 and is headquartered in Zurich, Switzerland.

Okairos AG develops preventive and therapeutic vaccines against human chronic infectious diseases. Its products include genetic vaccines, adenovirus vector platform, and proprietary cell line. The company was founded by Riccardo Cortese, Alfredo Nicosia, and Antonella Folgori in 2007 and is headquartered in Basel, Switzerland.

BioMedPartners AG (BMP), is an independant venture capital firm headquartered in Basel, Switzerland. BMP originated in 2002 as Seed Capital Advisors AG. The firm manages sector-focused venture capital funds including BioMedInvest, BioMedInvest II and BioMedCredit. They specialize in the biomedical sector.

Part of Sator SpA, One Swiss Bank SA (Switzerland) is a company that provides investment advice. The company is based in Geneva, Switzerland. The company was founded in 2004 by Robert Pennone, Bénédict G. F. Hentsch. Grégoire Pennone has been the CEO of the company since 2015. One Swiss Bank SA (Switzerland was acquired by Banque Profil De Gestion SA on June 01, 2021 for $43.37 million.

Picodrill SA provides micromachining techniques for production of hole structures in glass and dielectric materials. The company was founded by M. Eric Lucien, Jean-Pierre Rosat, and Christian Schmidt on October 5, 2007 and is headquartered in Lausanne, Switzerland.

Inventages II invests in companies located in Bahamas. The fund focus on companies such as life science and consumer applications. It provides financing for seed, early and buyout capital requirements.

CeQur SA develops medical devices for diabetes patients. It offers n insulin delivery device that provides three days of consistent, basal insulin deliver along with on-demand bolus insulin. The company was founded by James L. Peterson in January 2008 and is headquartered in Horw, Switzerland.

Edimer Pharmaceuticals, Inc. provides biopharmaceutical products for improving the health and quality of life of families living with XLHED. It has developed EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), which is a rare orphan disease that causes symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. The company was founded by Pascal Schneider and Olivier Gaide in 2009 and is headquartered in Cambridge, MA.

Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland.

Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.

Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland.

Nacuity Pharmaceuticals, Inc. develops and markets pharmaceutical products. The company is headquartered in Fort Worth, TX.

iOnctura SA is a pre-clinical stage biopharmaceutical company focused on the research and development of novel immuno-oncology therapeutics for patients fighting cancer. The company was founded in June 2017 and is headquartered in Geneve, Switzerland.

Borealis Foods, Inc. is a Canadian sustainable food company that is committed to reducing their carbon footprint and creating innovative, healthier, and nourishing food for our bodies and the planet. The company is based in Oakville, Canada. The company is the first American producer of sustainable, plant-based ramen noodles made with organic pea protein. The company's production subsidiary, Palmetto Gourmet Foods, is one of the fastest-growing food companies in the industry, producing thousands of cups and packs per hour. The company was founded in 2020 by Reza Soltanzadeh and Barthélemy Helg, with Reza Soltanzadeh serving as the CEO since then.